Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
The New England Journal of Medicine
|
May 31, 2024
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks
Marc A Riedl, Henriette Farkas, Emel Aygören-Pürsün, et al.
The Journal of Allergy and Clinical Immunology
|
June 12, 2017
Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations
Jennifer W Leiding, Satoshi Okada, David Hagin, et al.
Journal of Clinical Immunology
|
November 26, 2015
The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1
Mark Depner, Sebastian Fuchs, Jan Raabe, et al.
The Lancet. Haematology
|
March 22, 2026
Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trial
Marcus Maurer, Marcin Stobiecki, Anna Valerieva, et al.
The World Allergy Organization Journal
|
June 19, 2026
Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trials
Emel Aygören-Pürsün, Danny M Cohn, Nancy Agmon-Levin, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 15, 2025
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohorts
Adrian Gervais, Francesca Trespidi, Alessandro Ferrari, et al.
Journal of Human Immunity
|
March 16, 2026
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohorts
Adrian Gervais, Francesca Trespidi, Alessandro Ferrari, et al.
The Journal of Allergy and Clinical Immunology
|
November 7, 2023
JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study
Marco Fischer, Peter Olbrich, Jérôme Hadjadj, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
March 13, 2026
ASSESSMENT OF TREC-BASED NBS SCID REPORTING PRACTICES FOR HARMONIZATION OF RESULTS AND INTERPRETATION: A GLOBAL SURVEY
Jahnavi Aluri, Amy Gaviglio, Isaac Kistler, et al.
Research Square
|
January 19, 2022
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies
Jeremy Manry, Paul Bastard, Adrian Gervais, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
The New England Journal of Medicine
|
May 31, 2024
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks
Marc A Riedl, Henriette Farkas, Emel Aygören-Pürsün, et al.
The Journal of Allergy and Clinical Immunology
|
June 12, 2017
Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations
Jennifer W Leiding, Satoshi Okada, David Hagin, et al.
Journal of Clinical Immunology
|
November 26, 2015
The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1
Mark Depner, Sebastian Fuchs, Jan Raabe, et al.
The Lancet. Haematology
|
March 22, 2026
Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trial
Marcus Maurer, Marcin Stobiecki, Anna Valerieva, et al.
The World Allergy Organization Journal
|
June 19, 2026
Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trials
Emel Aygören-Pürsün, Danny M Cohn, Nancy Agmon-Levin, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 15, 2025
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohorts
Adrian Gervais, Francesca Trespidi, Alessandro Ferrari, et al.
Journal of Human Immunity
|
March 16, 2026
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohorts
Adrian Gervais, Francesca Trespidi, Alessandro Ferrari, et al.
The Journal of Allergy and Clinical Immunology
|
November 7, 2023
JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study
Marco Fischer, Peter Olbrich, Jérôme Hadjadj, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
March 13, 2026
ASSESSMENT OF TREC-BASED NBS SCID REPORTING PRACTICES FOR HARMONIZATION OF RESULTS AND INTERPRETATION: A GLOBAL SURVEY
Jahnavi Aluri, Amy Gaviglio, Isaac Kistler, et al.
Research Square
|
January 19, 2022
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies
Jeremy Manry, Paul Bastard, Adrian Gervais, et al.
Page
of 10